Skip to Main Content

Author Details

Anton P Porsteinsson
University of Rochester, University of Rochester Medical Center
1996
111
37
PMIDPaper TitleJournal TitlePublished Year
36623419Effect of online tDCS to left somatomotor cortex on neuropsychiatric symptoms among older adults at risk for dementia.Cortex2023
37538343Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.Alzheimers Dement (N Y)2023
36958727A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.Expert Opin Pharmacother2023
37066690Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).Int Psychogeriatr2023
36324230Alzheimer's disease and related dementias: From risk factors to disease pathogenesis.Eur J Neurosci2022
32461027Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.Am J Geriatr Psychiatry2021
33781358Point-of-care research in dementia - another arrow in our quiver?Int Psychogeriatr2021
34425878Targeting autonomic flexibility to enhance cognitive training outcomes in older adults with mild cognitive impairment: study protocol for a randomized controlled trial.Trials2021
34661109Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies.Sleep Adv2021
34570180Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.JAMA Neurol2021
34101796Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.J Prev Alzheimers Dis2021
33949763Diagnostic criteria for apathy in neurocognitive disorders.Alzheimers Dement2021
32739240Attitudes Toward Computers Moderate the Effect of Computerized Cognitive Trainings in Oldest-Old Senior Living Center Residents.Am J Geriatr Psychiatry2021
32565008Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.Am J Geriatr Psychiatry2021
32463068Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies.J Prev Alzheimers Dis2020
33304988APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline.Alzheimers Dement (N Y)2020
32920620Editorial: The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) - A Fundamental Ally in AD Prevention Research.J Prev Alzheimers Dis2020
32787971Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.Alzheimers Res Ther2020
32463070Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting.J Prev Alzheimers Dis2020
32463069Early Detection of Mild Cognitive Impairment (MCI) in Primary Care.J Prev Alzheimers Dis2020
28913718Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology.Brain Imaging Behav2019
29347996The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.Trials2018
29914022Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.J Alzheimers Dis2018
29969907Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease.Am J Alzheimers Dis Other Demen2018
30246404Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.Health Serv Res2018
30577848Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial.Trials2018
30417070Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.Alzheimers Dement (Amst)2018
29448970Dementia clinical trial implications of mild behavioral impairment.Int Psychogeriatr2018
29616702Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force.J Prev Alzheimers Dis2018
27716674Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.J Alzheimers Dis2017
28300462An update on the advancements in the treatment of agitation in Alzheimer's disease.Expert Opin Pharmacother2017
29182706Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.J Prev Alzheimers Dis2017
27930899The cingulate cortex of older adults with excellent memory capacity.Cortex2017
27032628Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.Am J Psychiatry2016
29199323Clinical Benefits of Tramiprosate in Alzheimer's Disease Are Associated with Higher Number of APOE4 Alleles: The "APOE4 Gene-Dose Effect".J Prev Alzheimers Dis2016
26303700Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.J Geriatr Psychiatry Neurol2016
26611790A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.J Pharmacokinet Pharmacodyn2016
26525995Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment.Am J Geriatr Psychiatry2016
27665036Dazed and Confused: Medical Cannabis in Alzheimer Disease.Am J Geriatr Psychiatry2016
27145364R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.Br J Clin Pharmacol2016
27115509Principal components analysis of agitation outcomes in Alzheimer's disease.J Psychiatr Res2016
27472880Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment.J Alzheimers Dis2016
27321608Cognitive and Neural Effects of Vision-Based Speed-of-Processing Training in Older Adults with Amnestic Mild Cognitive Impairment: A Pilot Study.J Am Geriatr Soc2016
27178862ERP C250 shows the elderly (cognitively normal, Alzheimer's disease) store more stimuli in short-term memory than Young Adults do.Clin Neurophysiol2016
27567808Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.J Alzheimers Dis2016
26771737Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.Am J Psychiatry2016
26736036Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease.J Psychiatr Res2016
26905050Mental Fatigability and Heart Rate Variability in Mild Cognitive Impairment.Am J Geriatr Psychiatry2016
25311499Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.Int Psychogeriatr2015
26305876Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.Int Psychogeriatr2015
  • 1 - 50 of 111

Recommended Authors

Scott A Sperling
Center for Neurological Restoration, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 0
Sang Joon Son
Ajou University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Kelly L Sloane
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 3
Rita Khoury
Saint Louis University
Career Start Year 2009
Number of shared co-authors 0
Deniz Erten-Lyons
Oregon Health and Science University
Career Start Year 2006
Number of shared co-authors 9
Lei Yu
Rush University Medical Center
Career Start Year 2006
Number of shared co-authors 57
Jonathan Graff-Radford
Mayo Clinic Rochester
Career Start Year 2006
Number of shared co-authors 23
Huali Wang
Peking University, Institute of Mental Health (Sixth Hospital)
Career Start Year 2004
Number of shared co-authors 10
Paul K Crane
University of Washington
Career Start Year 2003
Number of shared co-authors 65
Jordan J Elm
Medical University of South Carolina
Career Start Year 2002
Number of shared co-authors 0
Moon Ho Park
Korea University Ansan Hospital, Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 0
Eric McDade
Washington University St. Louis
Career Start Year 1998
Number of shared co-authors 48
Ruth O'Hara
Stanford University School of Medicine
Career Start Year 1995
Number of shared co-authors 12
Steven D Edland
University of California San Diego
Career Start Year 1993
Number of shared co-authors 31
David S Geldmacher
University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 18
Adam L Boxer
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1992
Number of shared co-authors 83
Bradley F Boeve
Mayo Clinic Rochester
Career Start Year 1991
Number of shared co-authors 87
Wayne C McCormick
University of Washington
Career Start Year 1990
Number of shared co-authors 45
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 4
Carol A Manning
University of Virginia
Career Start Year 1988
Number of shared co-authors 9
David A Bennett
Rush University Medical Center
Career Start Year 1987
Number of shared co-authors 92
James D Bowen
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 45
Simon Lovestone
Janssen Medical Ltd
Career Start Year 1986
Number of shared co-authors 65
Barry W Rovner
Sidney Kimmel Medical College at Thomas Jefferson University
Career Start Year 1985
Number of shared co-authors 6
Joel H Kramer
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1985
Number of shared co-authors 83
James B Leverenz
Lou Ruvo Center for Brain Health, Cleveland Clinic
Career Start Year 1980
Number of shared co-authors 66
Jason Brandt
The Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 22
Eric B Larson
University of Washington
Career Start Year 1977
Number of shared co-authors 60
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 9
Dilip V Jeste
Neurosciences University of California San Diego
Career Start Year 1969
Number of shared co-authors 17

Collaborators

Jacobo E Mintzer
Inc., Medical University of South Carolina
Co-authored papers 35
Lon S Schneider
Keck School of Medicine (EJ, University of Southern California
Co-authored papers 29
Pierre N Tariot
Banner Alzheimer's Institute
Co-authored papers 16
Jerome A Yesavage
Stanford University School of Medicine
Co-authored papers 14
Peter V Rabins
Johns Hopkins School of Medicine
Co-authored papers 13
Marwan N Sabbagh
Barrow Neurological Institute
Co-authored papers 11
Christopher H van Dyck
Yale University School of Medicine
Co-authored papers 9
Alan J Lerner
Case Western Reserve University
Co-authored papers 7
Reisa A Sperling
Brigham and Women's Hospital, Massachusetts General Hospital
Co-authored papers 6
Stephen Salloway
Butler Hospital, and Warren Alpert Medical School of Brown University
Co-authored papers 5
Paul S Aisen
Alzheimer's Therapeutic Research Institute, University of Southern California
Co-authored papers 5
Allan I Levey
Emory University School of Medicine
Co-authored papers 5
Lawrence S Honig
University of California
Co-authored papers 4
Nick C Fox
UK Dementia Research Institute, University College London
Co-authored papers 4
Kelly M Makino
University of Hawaii School of Medicine
Co-authored papers 4
John F Crary
Co-authored papers 4
Enchi Liu
Inc. 0 Shoreline Court
Co-authored papers 4
Martin R Farlow
Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM)
Co-authored papers 3
Ronald G Thomas
University of California
Co-authored papers 3
Joy L Taylor
Stanford University
Co-authored papers 3
Clifford R Jack
Mayo Clinic Rochester
Co-authored papers 3
Crystal V Flynn Longmire
Medical University of South Carolina
Co-authored papers 3
Chiadi U Onyike
Johns Hopkins University School of Medicine
Co-authored papers 3
M Saleem Ismail
University of Rochester Medical Center, Monroe Community Hospital
Co-authored papers 3
Pudugramam Murali Doraiswamy
Duke University School of Medicine
Co-authored papers 3
Jeffrey Kaye
Oregon Center for Aging & Technology
Co-authored papers 2
John A Robbins
Department of Medicine University of California Davis Davis CA USA.
Co-authored papers 2
Adam S Fleisher
Banner Alzheimer's Institute, University of California
Co-authored papers 2
Douglas W Scharre
Ohio State University
Co-authored papers 2
Dimitrios Avramopoulos
Johns Hopkins School of Medicine
Co-authored papers 2
Release 1.2